- Home
- PTCT
PTCT
PTC Therapeutics Inc.
as 11-21-2024 4:00pm EST
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | WARREN |
| Market Cap: | N/A | IPO Year: | 2013 |
| Target Price: | $42.58 | AVG Volume (30 days): | 743.9K |
| Analyst Decision: | Hold | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $20.75 - $46.98 | Next Earning Date: | 11-07-2024 |
| Revenue: | $900,664,000 | Revenue Growth: | 12.84% |
| Revenue Growth (this year): | -18.74% | Revenue Growth (next year): | -6.53% |
Latest PTC Therapeutics Inc. News
PTCT Breaking Stock News: Dive into PTCT Ticker-Specific Updates for Smart Investing
Benzinga
7 days ago
FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain
Pharmaceutical Technology
7 days ago
FDA grants accelerated approval for PTC’s AADC deficiency gene therapy
MT Newswires
7 days ago
Sector Update: Health Care Stocks Advance Pre-Bell Thursday
BioPharma Dive
8 days ago
PTC wins US approval of gene therapy for fatal enzyme disorder
MT Newswires
8 days ago
PTC Therapeutics Receives FDA Acceslerated Approval for Rare Brain Disease Deficiency Treatment
PR Newswire
8 days ago
PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy
Simply Wall St.
12 days ago
PTC Therapeutics Third Quarter 2024 Earnings: Beats Expectations
GuruFocus.com
13 days ago
PTC Therapeutics Inc (PTCT) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
Compare PTCT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PTCT PTC Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.